RNA has been making higher highs since October, and is now back above the major EMAs on the daily chart. Currently trying to break above the $13 pivot, with plenty of move to run. RSI seems healthy, riding just under overbought.
IPO intraday trading strategy idea
Avidity Biosciences is pioneering a new class of oligonucleotide-based therapies called AOCs designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still...